Introduction
Matrix metalloproteinases (MMPs) are a family of structurally related zincdependent neutral endopeptidases that play major roles in tissue remodeling occurring in a variety of physiological processes such as embryonic development, angiogenesis and wound healing (1, 2) . They are main effectors of pathological extracellular matrix destruction in many diseases such as arthritis, atherosclerosis, age-related macular degeneration, tumor invasion and metastasis (3) (4) (5) (6) (7) . MMPs contribute to the fine tuning of diverse biological processes through limited proteolysis of specific targets including not only matrix components, but also growth factors, chemokines/cytokines and cell surface receptors (8) (9) (10) (11) . More than 20 different human MMPs have been identified (12) and classified into different subfamilies according to their primary structure, domain organization, cellular localization and substrate specificity (11, 13, 14) . Produced as latent forms, they are either secreted in the extracellular medium or associated to the cell membrane (Membrane-type MMPs or MT-MMPs) (7, 11, 14) .
Among MMPs, MMP-19 displays unique structural features and tissue distribution.
Human MMP-19 cDNA was initially cloned from liver and mammary gland and was also identified as an autoantigen in inflamed rheumatoid synovium (15, 16) . presents the typical domain organization of soluble MMPs, including a signal sequence, a propeptide maintaining enzyme latency, a catalytic domain with the typical zinc binding motif, a linker region, and a C-terminal fragment with sequence similarity to hemopexin (15) . However, MMP-19 displays several structural features distinctive of the diverse MMP subfamilies including (i) an unique insertion of glutamic acid residues within the linker region, (ii) an unusual latency motif in propeptide domain, (iii) an additional cysteine residue in catalytic region, (iv) a C-terminal extension lacking 4 sequence similarity to equivalent regions in other human MMPs (15, 17, 18) . The catalytic domain of MMP-19 is capable of degrading components of basement membrane (laminin, type IV collagen, nidogen), connective tissue (fibronectin, type I gelatine) and cartilage (cartilage oligomeric matrix protein and aggrecan), but does not degrade triple-helical type I collagen (19, 20) . In contrast to most other MMPs, MMP-19 is expressed in human mammary or skin epithelial cells under normal quiescent conditions and down regulated in invasive carcinomas (21) (22) (23) . Transplantation assay in mice. PDVA cells were generated by in vitro carcinogen treatment (DMA) of cultured keratinocytes issued from B10LP mice (27) . PDVA cells were grown in modified Eagle's minimal essential medium containing a 4-fold concentration of amino acids and vitamins (Gibco Laboratories, Grant Island, NY), 10% fetal calf serum (Gibco) and antibiotics in a humidified incubator at 37 °C, 5% CO2.
Materials and Methods

Mmp
Cells (2 x 10
5 ) were seeded on a collagen gel (4 mg/mL of type I collagen isolated from rat tail tendons) inserted in Teflon rings (Renner GmbH, Dannstadt, Germany). After 24h of culture, cell-coated collagen gels were covered with a silicone transplantation chamber (Renner GmbH) and implanted in toto onto dorsal muscle fascia of 6-8 weeks old mice according to the procedure previously described (28, 29 to infiltrate it and all samples were scored + (Fig. 1A) . Tumor vascularization in Mmp-19-/-mice was increased since 63% and 37% of transplants were scored + and ++, respectively ( Fig. 1B) (P<0.05, χ 2 test). At that time, in both genotypes, tumor layer appeared as an irregular stratified epithelium on top of the collagen gel (Fig. 1A) .
Vascularization of tumor transplants at day 14 was first quantified by measuring the distance ("d") separating the bottom of tumor layer from the front of migrating blood vessels (Fig. 1D ). This parameter is inversely related to the degree of endothelial cell migration. Compared to Mmp-19+/+ mice, vessels migrated over a higher distance in Mmp-19-deficient mice (Fig. 1D) . Indeed, the distance separating endothelial cells to malignant keratinocytes was 2.5 fold reduced in Mmp-19 null mice than in their corresponding wild-type littermates (P=0.0062, Mann-Whitney test) (Fig. 1D) .
The observed increased blood vessel migration in Mmp-19-null mice prompted us to set up a more objective quantitative method to investigate the spatial distribution of 11 blood vessels in the remodeled matrix. With this aim, an original method based on computer-assisted image analysis was developed (Fig. 2) . The density of vessels picked already at a distance of around 0.25 mm from the upper boundary of tumor layer in
Mmp-19-/-mice (Fig. 2B) . In sharp contrast, the maximal density of endothelial cells was observed at a distance of around 0.75 mm in Mmp-19+/+ mice. A computerassisted method of image analysis was also set up to quantify tumor cell invasion ( Fig.   2A ). At day 14 time point, no invasion was observed (Fig. 2C) . This was expected since in the transplantation chamber assay, infiltration of vessels through the collagen gel towards tumor cells always precedes recognizable tumor cell invasion (34) . Therefore, at early time point, Mmp-19-deficient mice exhibited an acceleration of blood vessel infiltration in the remodeled matrix.
Lack of Mmp-19 increased tumor invasion
At day 21, once blood vessels have reached tumor cell layers, malignant keratinocytes formed tumor sprouts that invaded downwards the remodeled host tissue and were intermingled with closely apposed new vessels (Fig. 1A) . Such vascularization pattern scored +++ was observed in about 60% (10/17) of Mmp-19-/-mice and only 22% (4/18) of Mmp-19+/+ mice (P = 0.027, χ 2 test) (Fig. 1C) .
At this time point, the distance ("d") separating tumor layer from the front of recruited blood vessels ( Fig. 1) can not be measured since in more than 70% of tumor transplants, vessels have reached the tumor layer (tumors scored ++ or +++). Therefore, for quantitative assessment, our original method of image analysis (Fig. 2 ) was applied to determine the malignant keratinocyte density as a function of the distance to the top of tumor transplant (Fig. 2D) . In wild-type mice, keratinocyte density decreased abruptly with the distance to the top of tumor layer (Fig. 2D ). Only few keratinocytes were observed at a distance higher than 0. 
Mmp-19 is produced by host stromal cells
As a first step in determining the cellular source of Mmp-19, in situ hybridization was performed on tumors transplanted into Mmp-19 proficient and deficient mice. Hybridization signals for Mmp-19 mRNAs were found in the stroma of WT mice (Fig. 4A ), but not in that of KO mice (Fig. 4C) . No positive signal was detected after treatment with sense riboprobe used as negative controls (Fig. 4B ).
Immunohistochemical staining of tumor transplants confirmed the stromal production of Mmp-19 (Fig. 5A ). This protease was produced by mesenchymal cells (Fig. 5A ), but not by inflammatory cells positive for CD11b staining (Fig. 5C ). Interestingly, was not associated with capillaries newly formed in the remodelled collagen matrix 13 (data not shown). In contrast, Mmp-19 staining was detected in large vascular structures present deeply in the host tissue, below tumor transplants (Fig. 5B ). These vessels were positive for α-smooth muscle actin and correspond to quiescent mature vessels.
Lack of Mmp-19 increased angiogenesis in Matrigel plug assay
To further investigate the impact of Mmp-19 deficiency on angiogenesis in vivo and to determine whether the angiogenic response was dependent upon the matrix encountered by endothelial cells during their migration, the Matrigel plug assay was applied to mutant mice. Matrigel supplemented with bFGF was sub-cutaneously injected into the abdomen of wild type and mutant mice (n = 8) and harvested after 7
days. Quantitative analysis of angiogenesis was performed by measuring haemoglobin content in implants giving quantitative information on functional vessels. In accordance to results obtained in transplantation chamber assay, the angiogenic response in Mmp-19 deficient mice was 6-fold increased as compared to that detected in wild type mice ( Fig. 6 ) (P< 0.05) and was therefore independent on the type of matrix used (type I collagen versus a reconstituted basement membrane).
Discussion
The analysis of cancer susceptibility in individual Mmp-null mice is of growing interest after the failure of synthetic MMP inhibitors in clinical trials and the finding of multiple and even opposite roles of MMPs in tumor progression. We describe here that in contrast to most MMP deficiencies described up to now in mice, the angiogenic response was accelerated and tumor invasion was increased in Mmp-19-deficient mice. 
